134 related articles for article (PubMed ID: 12593893)
1. Lack of anti-D in women at birth following antepartum immune globulin prophylaxis.
Rudensky B; Mazaki E; Na'amad M; Samueloff A
Eur J Obstet Gynecol Reprod Biol; 2003 Mar; 107(1):45-6. PubMed ID: 12593893
[TBL] [Abstract][Full Text] [Related]
2. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
Bowman JM; Pollock JM
Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
[TBL] [Abstract][Full Text] [Related]
3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
4. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
5. Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?
Koby L; Grunbaum A; Benjamin A; Koby R; Abenhaim HA
J Obstet Gynaecol Can; 2012 May; 34(5):429-435. PubMed ID: 22555135
[TBL] [Abstract][Full Text] [Related]
6. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
7. Postinjection kinetics of antepartum Rh immune globulin.
Witter FR; Shirey RS; Nicol SL; Ness PM
Am J Obstet Gynecol; 1990 Sep; 163(3):784-6. PubMed ID: 2169705
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
9. Peripartum factors predicting the need for increased doses of postpartum rhesus immune globulin.
Leyenaar L; Allen VM; Robinson HE; Parsons M; Van den Hof MC
J Obstet Gynaecol Can; 2010 Aug; 32(8):739-44. PubMed ID: 21050504
[TBL] [Abstract][Full Text] [Related]
10. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.
Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS
BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468
[TBL] [Abstract][Full Text] [Related]
12. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
Crane JP; Rohland B; Larson D
Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
[TBL] [Abstract][Full Text] [Related]
13. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of anti-D IgG in pregnant RhD-negative women.
Bichler J; Schöndorfer G; Pabst G; Andresen I
BJOG; 2003 Jan; 110(1):39-45. PubMed ID: 12504934
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study.
Tiblad E; Wikman A; Rane A; Jansson Y; Westgren M
Acta Obstet Gynecol Scand; 2012 May; 91(5):587-92. PubMed ID: 22352370
[TBL] [Abstract][Full Text] [Related]
16. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
Hensleigh PA
Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
20. Routine antenatal anti-D prophylaxis--is the protection adequate?
Davies J; Chant R; Simpson S; Powell R
Transfus Med; 2011 Dec; 21(6):421-6. PubMed ID: 21906191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
